跳转至内容
Merck

P0052

Sigma-Aldrich

PNU-74654

≥98% (HPLC), solid

别名:

苯甲酸,2-苯氧基-,2-[(5-甲基-2-呋喃基)亚甲基]酰胺

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C19H16N2O3
分子量:
320.34
MDL號碼:
分類程式碼代碼:
12352203
PubChem物質ID:
NACRES:
NA.77

品質等級

化驗

≥98% (HPLC)

形狀

solid

顏色

white to off-white

溶解度

DMSO: >10 mg/mL

儲存溫度

2-8°C

SMILES 字串

Cc1ccc(\C=N\NC(=O)c2ccccc2Oc3ccccc3)o1

InChI

1S/C19H16N2O3/c1-14-11-12-16(23-14)13-20-21-19(22)17-9-5-6-10-18(17)24-15-7-3-2-4-8-15/h2-13H,1H3,(H,21,22)/b20-13+

InChI 密鑰

JJEDWBQZCRESJL-DEDYPNTBSA-N

應用

PNU-74654已被:
  • 作为β-连环蛋白信号转导抑制剂,研究对乌贼胚漏斗软骨分化的影响
  • 作为Wnt信号抑制剂,研究其对前列腺癌细胞系糖原合成酶激酶3 (GSK-3)的抑制作用
  • 作为Wnt信号通路抑制剂,研究其对瘦素诱导的乳腺癌细胞增殖的影响

生化/生理作用

PNU-74654 通过阻断 β-连环蛋白和 TCF(T 细胞因子)抑制 Wnt-β。PNU-74654 也是一种抗肿瘤药物。Wnt /β-catenin通路(经典通路)的异常激活通过β-catenin和T细胞因子(TCF)之间的相互作用参与驱动不同肿瘤(如结肠癌)的发生/发展,T细胞因子分解细胞增殖和分化中靶基因的表达。在癌细胞系中抑制该通路活性可有效阻断其生长。PNU-74654通过抑制β-catenin和TCF之间的相互作用抑制该通路。

象形圖

Exclamation mark

訊號詞

Warning

危險聲明

危險分類

Acute Tox. 4 Oral

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Letícia F Leal et al.
Oncotarget, 6(40), 43016-43032 (2015-10-31)
To date, there is no effective therapy for patients with advanced/metastatic adrenocortical cancer (ACC). The activation of the Wnt/beta-catenin signaling is frequent in ACC and this pathway is a promising therapeutic target. To investigate the effects of the inhibition of
Jieun Lee et al.
Biochemical and biophysical research communications, 525(3), 563-569 (2020-03-03)
Supercentenarians (≥110-year-old, SC) are a uniquely informative population not only because they surpass centenarians in age, but because they appear to age more slowly with fewer incidences of chronic age-related disease than centenarians. We reprogramed donor B-lymphoblastoid cell lines (LCL)
Rudolf Käfer et al.
International immunopharmacology, 32, 118-124 (2016-01-30)
Many tumors are characterized by mutation-induced constitutive activation of β-catenin which promotes tumor growth and survival. Consequently, the development of specific β-catenin inhibitors for tumor therapy has come into the focus of drug development. β-Catenin was also shown to contribute
Hong Quan Duong et al.
Cancer research, 78(16), 4533-4548 (2018-06-20)
MAPK signaling pathways are constitutively active in colon cancer and also promote acquired resistance to MEK1 inhibition. Here, we demonstrate that BRAFV600E -mutated colorectal cancers acquire resistance to MEK1 inhibition by inducing expression of the scaffold protein CEMIP through a
S M Hassanian et al.
Journal of thrombosis and haemostasis : JTH, 14(11), 2261-2273 (2016-08-23)
Essentials Polyphosphate (polyP) activates mTOR but its role in Wnt/β-catenin signaling is not known. PolyP-mediated cyclin D1 expression (β-catenin target gene) was monitored in endothelial cells. PolyP and boiled platelet-releasates induced the expression of cyclin D1 by similar mechanisms. PolyP

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门